{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:09:48Z","timestamp":1790190588964,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG24449"],"award-info":[{"award-number":["IG24449"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["F53D23012310001"],"award-info":[{"award-number":["F53D23012310001"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbcan.2025.189510","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T23:17:57Z","timestamp":1765063077000},"page":"189510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance"],"prefix":"10.1016","volume":"1881","author":[{"given":"Teresa","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Torcasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Ganino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaelena","family":"Pistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0005","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/ijms24010886","article-title":"Research of mitochondrial function, structure, dynamics and intracellular organization","volume":"24","author":"Kuznetsov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189510_bb0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tibs.2020.02.001","article-title":"Outlining the complex pathway of mammalian Fe-S cluster biogenesis","volume":"45","author":"Maio","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2025.189510_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2025.03.006","article-title":"The Warburg effect: the hacked mitochondrial-nuclear communication in cancer","volume":"112","author":"Jiang","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Sig. Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0025","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100067R","article-title":"Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis","volume":"35","author":"Adebayo","year":"2021","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.molcel.2023.02.012","article-title":"Determinants and outcomes of mitochondrial dynamics","volume":"83","author":"Quintana-Cabrera","year":"2023","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1186\/s12967-025-07078-x","article-title":"The molecular mechanisms of mitochondrial dynamics and mitophagy and their complex association with cancer drug resistance","volume":"23","author":"Zhao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1083\/jcb.201007152","article-title":"Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells","volume":"191","author":"Otera","year":"2010","journal-title":"J. Cell Biol."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189510_bb0050","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.jmb.2018.07.027","article-title":"Mechanisms orchestrating mitochondrial dynamics for energy homeostasis","volume":"430","author":"Yu","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189510_bb0055","doi-asserted-by":"crossref","first-page":"15787","DOI":"10.3390\/ijms242115787","article-title":"The Warburg effect explained: integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation","volume":"24","author":"Alberghina","year":"2023","journal-title":"IJMS"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189510_bb0060","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","article-title":"The Warburg effect: a signature of mitochondrial overload","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","article-title":"Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives","volume":"11","author":"Shi","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2025.189510_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcdb.2024.02.001","article-title":"The interplay between mitochondrial dynamics and autophagy: from a key homeostatic mechanism to a driver of pathology","volume":"161\u2013162","author":"Lacombe","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"issue":"87","key":"10.1016\/j.bbcan.2025.189510_bb0075","article-title":"The role of mitochondrial quality surveillance in skin aging: focus on mitochondrial dynamics, biogenesis and mitophagy","author":"Zhang","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"75","key":"10.1016\/j.bbcan.2025.189510_bb0080","article-title":"Mitochondrial dynamics and mitochondrial autophagy: molecular structure, orchestrating mechanism and related disorders","author":"Wang","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbcan.2025.189510_bb0085","first-page":"9","article-title":"Mitochondria lead the way: mitochondrial dynamics and function in cellular movements in development and disease","author":"Madan","year":"2022","journal-title":"Front. Cell Dev. Biol. [Internet]"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0090","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.ymthe.2022.01.032","article-title":"Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors","volume":"30","author":"Wang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2025.189510_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ebiom.2019.09.017","article-title":"Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer","volume":"48","author":"Seo","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189510_bb0100","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/1878-0261.13578","article-title":"Mitochondrial fusion\u2013fission dynamics and its involvement in colorectal cancer","volume":"18","author":"Wu","year":"2024","journal-title":"Mol. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/cancers10060189","article-title":"The roles of p53 in mitochondrial dynamics and cancer metabolism: the pendulum between survival and death in breast cancer?","volume":"10","author":"Moulder","year":"2018","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189510_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107537","article-title":"Ets1 facilitates EMT\/invasion through Drp1-mediated mitochondrial fragmentation in ovarian cancer","volume":"26","author":"Ghosh","year":"2023","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0115","article-title":"Mitofusin-2 promotes the epithelial-mesenchymal transition-induced cervical cancer progression","volume":"21","author":"Ahn","year":"2021","journal-title":"Immune Network [Internet]"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12967-023-04141-3","article-title":"Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer","volume":"21","author":"Xu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/biom13010050","article-title":"Hypoxia-inducible factor 1 and mitochondria: an intimate connection","volume":"13","author":"Huang","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189510_bb0130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/humu.23033","article-title":"Biallelic mutations in DNM1L are associated with a slowly progressive infantile encephalopathy","volume":"37","author":"Nasca","year":"2016","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189510_bb0135","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/hmg\/ddad029","article-title":"Disease-associated mutations in Drp1 have fundamentally different effects on the mitochondrial fission machinery","volume":"32","author":"Bauer","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2025.189510_bb0140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/PGPM.S314860","article-title":"Mitochondrial dynamics related genes -MFN1, MFN2 and DRP1 polymorphisms are associated with risk of lung cancer","volume":"14","author":"Liang","year":"2021","journal-title":"PGPM"},{"issue":"696","key":"10.1016\/j.bbcan.2025.189510_bb0145","article-title":"Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition","author":"Satoh","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189510_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107594","article-title":"New perspectives on the role of Drp1 isoforms in regulating mitochondrial pathophysiology","volume":"213","author":"Rosdah","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189510_bb0155","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.3390\/ijms23147897","article-title":"Mitochondrial genetic and epigenetic regulations in cancer: therapeutic potential","volume":"23","author":"Wagner","year":"2022","journal-title":"IJMS"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189510_bb0160","first-page":"8011","article-title":"The anti-tumor effects of Mfn2 in breast cancer are dependent on promoter DNA methylation, the P21Ras motif and PKA phosphorylation site","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189510_bb0165","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-21-0436","article-title":"Epigenetic induction of mitochondrial fission is required for maintenance of liver cancer\u2013initiating cells","volume":"81","author":"Tang","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189510_bb0170","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00523.2018","article-title":"Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology","author":"Adaniya","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol. [Internet]"},{"issue":"21\u221222","key":"10.1016\/j.bbcan.2025.189510_bb0175","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1080\/15384101.2023.2289753","article-title":"The mystery of phospho-Drp1 with four adaptors in cell cycle: when mitochondrial fission couples to cell fate decisions","volume":"22","author":"Wu","year":"2023","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189510_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/biom11030424","article-title":"The phosphorylation status of Drp1-Ser637 by PKA in mitochondrial fission modulates mitophagy via PINK1\/parkin to exert multipolar spindles assembly during mitosis","volume":"11","author":"Ko","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0185","article-title":"Intricate role of DRP1 and associated mitochondrial fission signaling in carcinogenesis and cancer progression","volume":"1880","author":"Mishra","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00790-2","article-title":"Fis1 phosphorylation by met promotes mitochondrial fission and hepatocellular carcinoma metastasis","volume":"6","author":"Yu","year":"2021","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.bbcan.2025.189510_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215871","article-title":"SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission","volume":"547","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ncrna9010016","article-title":"Non-coding RNA-dependent regulation of mitochondrial dynamics in cancer pathophysiology","volume":"9","author":"Gallo Cantafio","year":"2023","journal-title":"Non-Coding RNA"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189510_bb0205","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11427-022-2289-6","article-title":"A hidden translatome in tumors\u2014the coding lncRNAs","volume":"66","author":"Wang","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189510_bb0210","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41419-020-2584-z","article-title":"LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission","volume":"11","author":"Yi","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1878-0261.12866","article-title":"Long non-coding RNA RACGAP1P promotes breast cancer invasion and metastasis via miR-345-5p\/RACGAP1-mediated mitochondrial fission","volume":"15","author":"Zhou","year":"2021","journal-title":"Mol. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0220","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1159\/000484507","article-title":"LncRNA UCA1 promotes mitochondrial function of bladder cancer via the MiR-195\/ARL2 signaling pathway","volume":"43","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102825","article-title":"Mitochondria-localized lncRNA HITT inhibits fusion by attenuating formation of mitofusin-2 homotypic or heterotypic complexes","volume":"299","author":"Wang","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189510_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103350","article-title":"The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics","volume":"24","author":"Porc\u00f9","year":"2021","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189510_bb0235","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/biomedicines11030693","article-title":"MiRNAs action and impact on mitochondria function, metabolic reprogramming and chemoresistance of cancer cells: a systematic review","volume":"11","author":"Rosolen","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2025.189510_bb0240","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.dib.2017.12.040","article-title":"Data of expression status of miR- 29a and its putative target mitochondrial apoptosis regulatory gene DRP1 upon miR-15a and miR-214 inhibition","volume":"16","author":"Jan","year":"2018","journal-title":"Data Brief"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189510_bb0245","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/15476286.2019.1600999","article-title":"MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells","volume":"16","author":"Purohit","year":"2019","journal-title":"RNA Biol."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189510_bb0250","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.3390\/cancers13194994","article-title":"The miR-27a\/FOXJ3 Axis dysregulates mitochondrial homeostasis in colorectal cancer cells","volume":"13","author":"Barisciano","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189510_bb0255","article-title":"Negatively regulated by miR-29c-3p, MTFR1 promotes the progression and glycolysis in lung adenocarcinoma via the AMPK\/mTOR signalling pathway","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0260","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbrc.2018.02.189","article-title":"Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma","volume":"497","author":"Tak","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"46","key":"10.1016\/j.bbcan.2025.189510_bb0265","doi-asserted-by":"crossref","first-page":"80981","DOI":"10.18632\/oncotarget.20941","article-title":"microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canlet.2015.03.045","article-title":"miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1","volume":"362","author":"Fan","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189510_bb0275","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2018.4380","article-title":"miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission","author":"Pan","year":"2018","journal-title":"Int. J. Oncol. [Internet]"},{"key":"10.1016\/j.bbcan.2025.189510_bb0280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.canlet.2017.09.035","article-title":"MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression","volume":"410","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2025.189510_bb0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yexcr.2018.10.013","article-title":"MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells","volume":"373","author":"Luan","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189510_bb0290","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.18632\/oncotarget.3659","article-title":"Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p\u2013MFF axis","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189510_bb0295","article-title":"Mitochondria: a crucial factor in the progression and drug resistance of colorectal cancer","author":"Zhao","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189510_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003453","article-title":"Targeting mitochondrial structure and dynamics for therapeutic intervention in cancer","volume":"23","author":"Iwata","year":"2025","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41419-025-07878-5","article-title":"Metastatic breast cancer cells are selectively dependent on the mitochondrial cristae-shaping protein OPA1","volume":"16","author":"Diokmetzidou","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189510_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151225","article-title":"Mitochondrial and metabolic alterations in cancer cells","volume":"101","author":"Di Gregorio","year":"2022","journal-title":"Eur. J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0315","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41580-020-00300-2","article-title":"Quality control of the mitochondrial proteome","volume":"22","author":"Song","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189510_bb0325","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.3390\/ijms22094770","article-title":"Mitochondria: insights into crucial features to overcome cancer chemoresistance","volume":"22","author":"Genovese","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0330","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11033-025-10748-0","article-title":"Cancer stem cells: mitochondria signalling pathway and strategies for therapeutic interventions","volume":"52","author":"Tan","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0335","article-title":"Unraveling the role of mitochondrial dynamics in cancer stem cells: molecular basis and therapeutic implications","volume":"1880","author":"Giannitti","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189510_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116744","article-title":"Adenovirus-mediated expression of MOAP-1, Bax and RASSF1A antagonizes chemo-drug resistance of human breast cancer cells expressing cancer stem cell markers","volume":"176","author":"Tan","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0345","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189510_bb0355","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41419-021-03912-4","article-title":"Dynamic regulation of mitochondrial-endoplasmic reticulum crosstalk during stem cell homeostasis and aging","volume":"12","author":"Lin","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2018.05.021","article-title":"AMPK\/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells","volume":"23","author":"Pei","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189510_bb0365","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/2211-5463.13207","article-title":"The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy","volume":"11","author":"Liu","year":"2021","journal-title":"FEBS Open Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0370","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2019.05.004","article-title":"Epigenetic control of mitochondrial fission enables self-renewal of stem-like tumor cells in human prostate cancer","volume":"30","author":"Civenni","year":"2019","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0375","article-title":"Lipogenesis promotes mitochondrial fusion and maintains cancer stemness in human NSCLC","volume":"8","author":"Liu","year":"2023","journal-title":"JCI Insight [Internet]"},{"issue":"14","key":"10.1016\/j.bbcan.2025.189510_bb0380","doi-asserted-by":"crossref","first-page":"1101433","DOI":"10.3389\/fimmu.2023.1101433","article-title":"Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells","author":"Barbieri","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189510_bb0385","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189510_bb0390","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","article-title":"Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0395","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"issue":"49","key":"10.1016\/j.bbcan.2025.189510_bb0400","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi2465","article-title":"Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation","volume":"9","author":"Xiang","year":"2023","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0405","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001372","article-title":"Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1\u2013mediated immunoescape via STING-IFN signaling and extracellular vesicles","volume":"8","author":"Cheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0410","article-title":"Effects of PD-1 signaling on immunometabolic reprogramming","volume":"4","author":"Boussiotis","year":"2022","journal-title":"Immunometabol. [Internet]"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0415","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad277","article-title":"Nutritional competition within tumor microenvironment dictates anti-tumor immunity","volume":"11","author":"Fei","year":"2024","journal-title":"Natl. Sci. Rev."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0420","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189510_bb0425","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mito.2021.12.001","article-title":"Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: an evidence-based hypothesis","volume":"62","author":"Akbari","year":"2022","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0430","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","article-title":"Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells","volume":"17","author":"Saha","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189510_bb0435","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","article-title":"Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion","volume":"21","author":"Yu","year":"2020","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189510_bb0440","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41419-024-07122-6","article-title":"Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment","volume":"15","author":"Zheng","year":"2024","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0445","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","article-title":"Molecular mechanisms of mitochondrial dynamics","volume":"26","author":"T\u00e1bara","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189510_bb0450","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2025.189510_bb0455","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.molmed.2025.04.002","article-title":"Targeting mitochondrial transfer as a promising therapeutic strategy","volume":"10","author":"Li","year":"2025","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109979","article-title":"Hallmarks of cancer resistance","volume":"27","author":"Tufail","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2025.189510_bb0465","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","article-title":"Mitochondria as playmakers of apoptosis, autophagy and senescence","volume":"98","author":"Abate","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0470","article-title":"MOMP: a critical event in cell death regulation and anticancer treatment","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0475","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.bbcan.2025.189510_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109395","article-title":"Mitofusin-2 in cancer: friend or foe?","volume":"730","author":"Ramaiah","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"issue":"590","key":"10.1016\/j.bbcan.2025.189510_bb0485","article-title":"Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics","author":"Song","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189510_bb0490","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/biom15070970","article-title":"Targeting mitochondrial quality control for the treatment of triple-negative breast cancer: from molecular mechanisms to precision therapy","volume":"15","author":"Pei","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0495","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41420-025-02670-y","article-title":"Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions","volume":"11","author":"Qiu","year":"2025","journal-title":"Cell Death Discov."},{"issue":"48","key":"10.1016\/j.bbcan.2025.189510_bb0500","doi-asserted-by":"crossref","first-page":"45208","DOI":"10.1021\/acsomega.3c06547","article-title":"DRP1: at the crossroads of dysregulated mitochondrial dynamics and altered cell signaling in cancer cells","volume":"8","author":"Adhikary","year":"2023","journal-title":"ACS Omega"},{"issue":"14","key":"10.1016\/j.bbcan.2025.189510_bb0505","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41388-023-02596-8","article-title":"Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment","volume":"42","author":"Baek","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0510","doi-asserted-by":"crossref","first-page":"22782","DOI":"10.1038\/s41598-023-49578-0","article-title":"Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice","volume":"13","author":"Alalawy","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0515","first-page":"893","article-title":"Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases","volume":"4","author":"Parida","year":"2023","journal-title":"Nat. Can."},{"issue":"24","key":"10.1016\/j.bbcan.2025.189510_bb0520","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.7150\/jca.61379","article-title":"Mitochondrial dynamics mediated by DRP1 and MFN2 contributes to cisplatin chemoresistance in human ovarian cancer SKOV3 cells","volume":"12","author":"Zou","year":"2021","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0525","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/jmp4040023","article-title":"Mitochondrial dynamics in ovarian cancer: pathophysiology and therapeutic implications","volume":"4","author":"Kobayashi","year":"2023","journal-title":"J. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-025-07720-w","article-title":"CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells","volume":"8","author":"Zhu","year":"2025","journal-title":"Commun. Biol."},{"issue":"45","key":"10.1016\/j.bbcan.2025.189510_bb0535","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1038\/s41388-019-0949-5","article-title":"Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells","volume":"38","author":"Han","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0540","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/ijms24021224","article-title":"Ovarian cancer: a landscape of mitochondria with emphasis on mitochondrial dynamics","volume":"24","author":"De Rasmo","year":"2023","journal-title":"IJMS1"},{"issue":"21","key":"10.1016\/j.bbcan.2025.189510_bb0545","doi-asserted-by":"crossref","first-page":"20931","DOI":"10.18632\/aging.104207","article-title":"OPA1, a new mitochondrial target in cancer therapy","volume":"12","author":"Herkenne","year":"2020","journal-title":"Aging"},{"issue":"14","key":"10.1016\/j.bbcan.2025.189510_bb0550","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.3390\/cancers14143432","article-title":"Mitochondrial elongation and OPA1 play crucial roles during the stemness acquisition process in pancreatic ductal adenocarcinoma","volume":"14","author":"Carmona-Carmona","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-05768-2","article-title":"Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to gefitinib in a lung adenocarcinomaresistant cell line","volume":"14","author":"Noguchi","year":"2023","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189510_bb0560","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/1535-7163.MCT-20-1095","article-title":"Novel mitochondria-based targeting restores responsiveness in therapeutically resistant human lung cancer cells","volume":"20","author":"Yin","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189510_bb0565","article-title":"Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges","author":"Xiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189510_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166801","article-title":"Melanoma cells with acquired resistance to vemurafenib have decreased autophagic flux and display enhanced ability to transfer resistance","volume":"1869","author":"P\u00e9rez","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0575","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/ijms26062675","article-title":"Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant-melanoma to vemurafenib","volume":"26","author":"Prado-Souza","year":"2025","journal-title":"IJMS"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0580","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41375-023-01835-x","article-title":"Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia","volume":"37","author":"Larrue","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2025.189510_bb0585","article-title":"Mitofusin-2 mediates doxorubicin sensitivity and acute resistance in Jurkat leukemia cells","volume":"24","author":"Decker","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189510_bb0590","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41419-024-06864-7","article-title":"Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation","volume":"15","author":"Enzenm\u00fcller","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0595","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1186\/s12967-025-06942-0","article-title":"Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax","volume":"23","author":"Valentino","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0600","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12967-024-05013-0","article-title":"Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity","volume":"22","author":"Torcasio","year":"2024","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189510_bb0605","first-page":"2422","article-title":"Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma","volume":"110","author":"Cantafio","year":"2025","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113825","article-title":"Mitochondrial response of glioma cells to temozolomide","volume":"433","author":"Lenz","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189510_bb0615","article-title":"DRP1 Promotes BRAFV600E-driven tumor Progression and metabolic reprogramming in colorectal cancer","author":"Padder","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0620","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/15548627.2016.1166318","article-title":"Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways","volume":"12","author":"Huang","year":"2016","journal-title":"Autophagy"},{"issue":"24","key":"10.1016\/j.bbcan.2025.189510_bb0625","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/molecules25245793","article-title":"Inhibition of Drp1 sensitizes cancer cells to cisplatin-induced apoptosis through transcriptional inhibition of c-FLIP expression","volume":"25","author":"Woo","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0630","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","article-title":"Mitochondrial diseases: from molecular mechanisms to therapeutic advances","volume":"10","author":"Wen","year":"2025","journal-title":"Sig. Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0635","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10555-024-10211-9","article-title":"The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy","volume":"43","author":"Chen","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2025.189510_bb0640","doi-asserted-by":"crossref","DOI":"10.1515\/oncologie-2024-0596","article-title":"Multiple roles of mitochondria in tumorigenesis and treatment: from mechanistic insights to emerging therapeutic strategies","author":"Zhang","year":"2025","journal-title":"Oncologie [Internet]"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189510_bb0645","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00018-022-04595-6","article-title":"Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK\/mTOR\/ERK signaling","volume":"79","author":"Ashraf","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"16","key":"10.1016\/j.bbcan.2025.189510_bb0650","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126915","article-title":"Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer","volume":"4","author":"Yu","year":"2019","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189510_bb0655","article-title":"Mitochondrial quality control in hepatocellular carcinoma","author":"Bian","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0660","doi-asserted-by":"crossref","first-page":"10348","DOI":"10.1038\/s41598-018-28590-9","article-title":"Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics","volume":"8","author":"Kriel","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189510_bb0665","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jcmm.17147","article-title":"Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy","volume":"26","author":"Wang","year":"2022","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189510_bb0670","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/cancers14092155","article-title":"Divergent roles of mitochondria dynamics in pancreatic ductal adenocarcinoma","volume":"14","author":"Carmona-Carmona","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0675","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/labinvest.2012.144","article-title":"OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma","volume":"93","author":"Zhao","year":"2013","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0680","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41420-021-00495-z","article-title":"Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells","volume":"7","author":"Fang","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2025.189510_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107574","article-title":"Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells","volume":"150","author":"Sami Alkafaas","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2025.189510_bb0690","doi-asserted-by":"crossref","DOI":"10.3892\/or.2020.7476","article-title":"Suppression of DRP1-mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy","author":"Ma","year":"2020","journal-title":"Oncol. Rep. [Internet]"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189510_bb0695","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3892\/ijo.2014.2608","article-title":"Mitochondrial division inhibitor-1 induces mitochondrial hyperfusion and sensitizes human cancer cells to TRAIL-induced apoptosis","volume":"45","author":"Akita","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0700","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/cancers13040698","article-title":"Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential","volume":"13","author":"Courtois","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0705","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12964-015-0102-1","article-title":"Dynasore - not just a dynamin inhibitor","volume":"13","author":"Preta","year":"2015","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0710","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1096\/fj.201901467R","article-title":"Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury","volume":"34","author":"Wu","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0715","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1038\/s41467-023-40043-0","article-title":"Targeting an allosteric site in dynamin-related protein 1 to inhibit Fis1-mediated mitochondrial dysfunction","volume":"14","author":"Rios","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189510_bb0720","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/acsmedchemlett.3c00223","article-title":"Discovery of potent allosteric DRP1 inhibitors by disrupting protein\u2013protein interaction with MiD49","volume":"14","author":"Furuya","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0725","doi-asserted-by":"crossref","first-page":"21531","DOI":"10.1038\/s41598-022-25464-z","article-title":"A novel small molecule inhibitor of human Drp1","volume":"12","author":"Rosdah","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189510_bb0730","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4143\/crt.2020.1024","article-title":"Combination of simvastatin and FAC improves response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"53","author":"Yulian","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2025.189510_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111329","article-title":"Mitochondrial signaling pathways and their role in cancer drug resistance","volume":"122","author":"Sharma","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2025.189510_bb0740","first-page":"11","article-title":"Mitochondria-shaping proteins and chemotherapy","author":"Xie","year":"2021","journal-title":"Front. Oncol. [Internet]"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189510_bb0745","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Sig. Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189510_bb0750","first-page":"198","article-title":"The metabolic modulator PGC-1\u03b1 in cancer","volume":"9","author":"Bost","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189510_bb0755","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/1061186X.2015.1108325","article-title":"Mitochondria-targeted drug delivery system for cancer treatment","volume":"24","author":"Chen","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbcan.2025.189510_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123023","article-title":"Mitochondria-targeting materials and therapies for regenerative engineering","volume":"316","author":"Fu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2025.189510_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.918691","article-title":"MFN2 mediates ER-mitochondrial coupling during ER stress through specialized stable contact sites","volume":"10","author":"Gottschalk","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189510_bb0770","article-title":"Mechanical regulation of mitochondrial morphodynamics in cancer cells by extracellular microenvironment","volume":"14","author":"Lunova","year":"2024","journal-title":"Biomater. Biosyst."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:02:31Z","timestamp":1777554151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25002525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0304419X25002525"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189510","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189510"}}